UK markets closed

Gain Therapeutics, Inc. (GANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0300-0.0400 (-1.30%)
At close: 04:00PM EDT
3.0800 +0.05 (+1.65%)
After hours: 04:54PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate-0.29-0.32-1.22-1.18
Low estimate-0.39-0.42-1.6-1.59
High estimate-0.19-0.2-0.93-0.87
Year ago EPS-0.43-0.62-1.71-1.22
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2232
Avg. Estimate30k40k770k290k
Low estimateN/AN/AN/A170k
High estimate60k80k2M400k
Year ago sales55kN/A55k770k
Sales growth (year/est)-45.50%N/A1,300.00%-62.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.39-0.31-0.45-0.32
Actual EPS-0.43-0.62-0.37-0.36
Difference-0.04-0.310.08-0.04
Surprise %-10.30%-100.00%17.80%-12.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.29-0.32-1.22-1.18
7 days ago-0.29-0.29-1.19-1.13
30 days ago-0.29-0.24-1.12-1.06
60 days ago-0.29-0.24-1.12-1.06
90 days ago-0.31-0.27-1.16-1.25
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A21
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesGANXIndustrySector(s)S&P 500
Current qtr.32.60%N/AN/AN/A
Next qtr.48.40%N/AN/AN/A
Current year28.70%N/AN/AN/A
Next year3.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A